HOME › DRUGS › RUBOXISTAURIN
ACTIVE SUBSTANCE / INN

RUBOXISTAURIN

Brand name(s): Arxxant
EMA LISTED
APPLICATION WITHDRAWN
Diabetic Retinopathy
ACTIVE SUBSTANCE
Ruboxistaurin
REGULATORS
EMA
SPONSORS / MAH
Eli Lilly Nederland B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ArxxantEli Lilly Nederland B.V.Application withdrawnDiabetic Retinopathy

FULL INTELLIGENCE ON RUBOXISTAURIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →